title: Correlation between clinicopathology and expression of heat shock protein 70 and glucose-regulated protein 94 in human colonic adenocarcinoma.
abstract: OBJECTIVE
  To investigate the correlation between clinicopathology and expression of heat shock protein 70 (HSP70) and glucose-regulated protein 94 (grp94) in human colonic carcinoma.
  
  
  METHODS
  The expression of HSP70 and grp94 was studied in 80 human colonic cancers with or without metastasis as well as in their adjacent mucous membrane by way of immunohistochemistry and pathology photograph analysis.
  
  
  RESULTS
  The expression of HSP70 and grp94 was significantly higher in cancer than that in adjacent mucous membrane (92.5%, 85.0% vs 56.3%, 42.5%, P<0.01). HSP70 and grp94 expressed higher in moderately- and poorly-differentiated colonic cancers than that in their adjacent tissues (93.7%, 87.5%; 100%, 90% vs 56.3%, 42.5%; P<0.01). Dukes C and D stages of colonic cancers showed higher positive rates than Dukes A and B stage groups (97.1%, 91.2%; 100%, 90.9%; vs 80%, 70%; 78.6%, 71.4%; P<0.05). There were definite differences in HSP70 and grp94 expression between metastasis groups and non-metastasis groups (100% vs 75%, 100% vs 50%, P<0.05).
  
  
  CONCLUSIONS
  The HSP70 and grp94 expression rates in colonic cancer groups are significantly higher than that in their adjacent mucous membrane. The HSP70 and grp94 expression in poorly-differentiated colonic cancers with metastasis is significantly higher than well-differentiated cancers without metastasis. The overexpression of HSP70 and grp94 can be used as diagnostic or prognostic markers for colonic cancer.
authors.affiliation: Department of Pathology, Capital University of Medical Sciences, Beijing 100054, China. wxpphd@yahoo.com.cn
authors.forename: Xiao-Ping
authors.initials: XP
authors.lastname: Wang
authors.forename: Fan-Rong
authors.initials: FR
authors.lastname: Qiu
authors.forename: Guo-Zhen
authors.initials: GZ
authors.lastname: Liu
authors.forename: Rui-Fen
authors.initials: RF
authors.lastname: Chen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor; D002454:Cell Differentiation; D003110:Colonic Neoplasms / Q000378:metabolism* / Q000556:secondary*; D005260:Female; D018840:HSP70 Heat-Shock Proteins / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000378:metabolism / Q000473:pathology; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism*; D008875:Middle Aged; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D018840:HSP70 Heat-Shock Proteins; D008565:Membrane Proteins; C018551:glucose-regulated proteins
references.citation: Cancer Lett. 2003 Aug 20;198(2):219-28
references.pmid: 12957361
references.citation: Ann Oncol. 2001 May;12(5):615-20
references.pmid: 11432618
references.citation: Cancer Res. 1996 Mar 1;56(5):1104-10
references.pmid: 8640768
references.citation: Wien Med Wochenschr. 1988 Jun 30;138(11-12):267-70
references.pmid: 3176506
references.citation: Biochemistry. 2001 Feb 6;40(5):1483-95
references.pmid: 11170476
references.citation: Semin Cell Dev Biol. 1999 Oct;10(5):495-505
references.pmid: 10597632
references.citation: Cancer Immunol Immunother. 2004 Mar;53(3):227-33
references.pmid: 14689240
references.citation: Biomed Sci Instrum. 2003;39:389-96
references.pmid: 12724925
references.citation: EMBO J. 2001 Nov 15;20(22):6297-305
references.pmid: 11707401
references.citation: Exp Hematol. 1999 Nov;27(11):1627-36
references.pmid: 10560910
references.citation: Trends Biochem Sci. 2001 Aug;26(8):504-10
references.pmid: 11504627
references.citation: EMBO J. 2000 Apr 3;19(7):1516-24
references.pmid: 10747020
references.citation: J Biol Chem. 1999 Apr 23;274(17):12023-35
references.pmid: 10207025
references.citation: Exp Cell Res. 1997 Oct 10;236(1):268-74
references.pmid: 9344607
references.citation: J Biol Chem. 1990 Jul 25;265(21):12111-4
references.pmid: 2197269
references.citation: World J Gastroenterol. 2003 Aug;9(8):1853-5
references.pmid: 12918137
references.citation: Carcinogenesis. 2002 Jan;23(1):123-30
references.pmid: 11756233
references.citation: Traffic. 2001 Oct;2(10):690-7
references.pmid: 11576445
references.citation: Oncogene. 1999 Jun 10;18(23):3461-70
references.pmid: 10376524
references.citation: Cancer Immunol Immunother. 2003 Apr;52(4):226-34
references.pmid: 12669247
references.citation: Cancer. 2003 Sep 1;98(5):970-7
references.pmid: 12942564
references.citation: Radiother Oncol. 1990 Nov;19(3):197-218
references.pmid: 2149186
references.citation: Anticancer Res. 2003 Mar-Apr;23(2A):1057-62
references.pmid: 12820347
references.citation: Science. 1993 Mar 5;259(5100):1409-10
references.pmid: 8451637
references.citation: Int J Cancer. 2000 May 15;86(4):489-93
references.pmid: 10797260
references.citation: J Gastroenterol Hepatol. 2003 Jun;18(6):690-700
references.pmid: 12753152
references.citation: Chin Med J (Engl). 2002 Nov;115(11):1615-9
references.pmid: 12609072
references.citation: Breast Cancer Res Treat. 1999 Mar;54(2):135-46
references.pmid: 10424404
references.citation: Cell Res. 2000 Jun;10(2):115-25
references.pmid: 10896173